ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$28.10
+2.82%
Mkt Cap $1.29B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+60.2%
Consensus $45.00 vs current $28.10
NASDAQ·Healthcare·Biotechnology
$28.10
+2.82%
Mkt Cap $1.29B
Buy
8
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
+60.2%
Consensus $45.00 vs current $28.10